Usage of L-type calcium channel blockers to suppress drug reward and memory driving addiction: Past, present, and future

Over the past three decades, L-type Ca(2+) channel (LTCC) blockers have been considered a potential therapeutic drug to alleviate the symptoms of drug addiction. This idea has been supported, in part, by 1) expression of LTCCs in the brain dopaminergic circuits that are thought to play critical role...

Descripción completa

Detalles Bibliográficos
Autores principales: Morikawa, Hitoshi, Young, Cara C., Smits, Jasper A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476140/
https://www.ncbi.nlm.nih.gov/pubmed/36241085
http://dx.doi.org/10.1016/j.neuropharm.2022.109290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476140/
https://www.ncbi.nlm.nih.gov/pubmed/36241085
http://dx.doi.org/10.1016/j.neuropharm.2022.109290

Ejemplares similares